NASDAQ
PsyBio Therapeutics Corp. (PSYBF) has a current ratio of 0.13x as of Tuesday, May 26, 2026. This represents a 96.18% decrease compared to its 12-month average of 3.35x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.